GSK plc GLAXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.83% | -10.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.83% | -10.32% | |||
| Cost of Revenue | 10.23% | -27.50% | |||
| Gross Profit | 9.70% | -2.83% | |||
| SG&A Expenses | 4.75% | -20.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 66.95% | -43.55% | |||
| Total Operating Expenses | 19.03% | -29.52% | |||
| Operating Income | -6.34% | 71.92% | |||
| Income Before Tax | -83.55% | 128.62% | |||
| Income Tax Expenses | -165.01% | 38.55% | |||
| Earnings from Continuing Operations | -70.04% | 156.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -15.27% | -13.55% | |||
| Net Income | -75.05% | 176.67% | |||
| EBIT | -6.34% | 71.92% | |||
| EBITDA | -12.88% | 21.72% | |||
| EPS Basic | -74.99% | 176.34% | |||
| Normalized Basic EPS | -7.02% | 86.10% | |||
| EPS Diluted | -74.98% | 177.38% | |||
| Normalized Diluted EPS | -6.97% | 86.82% | |||
| Average Basic Shares Outstanding | -0.22% | 0.10% | |||
| Average Diluted Shares Outstanding | -0.29% | -0.29% | |||
| Dividend Per Share | -0.35% | -4.34% | |||
| Payout Ratio | 3.51% | -0.64% | |||